INHIBITORS OF HIF PROLYL HYDROXYLASE
The present invention concerns compounds of formula I or pharmaceutically acceptable salts thereof, which inhibit HIF prolyl hydroxylase, their use for enhancing endogenous production of erythropoietin, and for treating conditions associated with reduced endogenous production of erythropoietin such...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | LIU RONGQIANG WANG LIPING DUBOIS BYRON GABRIEL GUIADEEN DEODIALSINGH LIU PING SINZ CHRISTOPHER CAI JIAQIANG CRESPO ALEJANDRO KOTHANDARAMAN SHANKARAN DU XIAOXING QUAN WEIGUO |
description | The present invention concerns compounds of formula I or pharmaceutically acceptable salts thereof, which inhibit HIF prolyl hydroxylase, their use for enhancing endogenous production of erythropoietin, and for treating conditions associated with reduced endogenous production of erythropoietin such as anemia and like conditions, as well as pharmaceutical compositions comprising such a compound and a pharmaceutical carrier. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2017233412A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2017233412A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2017233412A13</originalsourceid><addsrcrecordid>eNrjZFDx9PPwdPIM8Q8KVvB3U_DwdFMICPL3ifRR8Ih0CfKPiPRxDHblYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBobmRsbGJoZGjobGxKkCABxxJBY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INHIBITORS OF HIF PROLYL HYDROXYLASE</title><source>esp@cenet</source><creator>LIU RONGQIANG ; WANG LIPING ; DUBOIS BYRON GABRIEL ; GUIADEEN DEODIALSINGH ; LIU PING ; SINZ CHRISTOPHER ; CAI JIAQIANG ; CRESPO ALEJANDRO ; KOTHANDARAMAN SHANKARAN ; DU XIAOXING ; QUAN WEIGUO</creator><creatorcontrib>LIU RONGQIANG ; WANG LIPING ; DUBOIS BYRON GABRIEL ; GUIADEEN DEODIALSINGH ; LIU PING ; SINZ CHRISTOPHER ; CAI JIAQIANG ; CRESPO ALEJANDRO ; KOTHANDARAMAN SHANKARAN ; DU XIAOXING ; QUAN WEIGUO</creatorcontrib><description>The present invention concerns compounds of formula I or pharmaceutically acceptable salts thereof, which inhibit HIF prolyl hydroxylase, their use for enhancing endogenous production of erythropoietin, and for treating conditions associated with reduced endogenous production of erythropoietin such as anemia and like conditions, as well as pharmaceutical compositions comprising such a compound and a pharmaceutical carrier.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170817&DB=EPODOC&CC=US&NR=2017233412A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170817&DB=EPODOC&CC=US&NR=2017233412A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LIU RONGQIANG</creatorcontrib><creatorcontrib>WANG LIPING</creatorcontrib><creatorcontrib>DUBOIS BYRON GABRIEL</creatorcontrib><creatorcontrib>GUIADEEN DEODIALSINGH</creatorcontrib><creatorcontrib>LIU PING</creatorcontrib><creatorcontrib>SINZ CHRISTOPHER</creatorcontrib><creatorcontrib>CAI JIAQIANG</creatorcontrib><creatorcontrib>CRESPO ALEJANDRO</creatorcontrib><creatorcontrib>KOTHANDARAMAN SHANKARAN</creatorcontrib><creatorcontrib>DU XIAOXING</creatorcontrib><creatorcontrib>QUAN WEIGUO</creatorcontrib><title>INHIBITORS OF HIF PROLYL HYDROXYLASE</title><description>The present invention concerns compounds of formula I or pharmaceutically acceptable salts thereof, which inhibit HIF prolyl hydroxylase, their use for enhancing endogenous production of erythropoietin, and for treating conditions associated with reduced endogenous production of erythropoietin such as anemia and like conditions, as well as pharmaceutical compositions comprising such a compound and a pharmaceutical carrier.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFDx9PPwdPIM8Q8KVvB3U_DwdFMICPL3ifRR8Ih0CfKPiPRxDHblYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBobmRsbGJoZGjobGxKkCABxxJBY</recordid><startdate>20170817</startdate><enddate>20170817</enddate><creator>LIU RONGQIANG</creator><creator>WANG LIPING</creator><creator>DUBOIS BYRON GABRIEL</creator><creator>GUIADEEN DEODIALSINGH</creator><creator>LIU PING</creator><creator>SINZ CHRISTOPHER</creator><creator>CAI JIAQIANG</creator><creator>CRESPO ALEJANDRO</creator><creator>KOTHANDARAMAN SHANKARAN</creator><creator>DU XIAOXING</creator><creator>QUAN WEIGUO</creator><scope>EVB</scope></search><sort><creationdate>20170817</creationdate><title>INHIBITORS OF HIF PROLYL HYDROXYLASE</title><author>LIU RONGQIANG ; WANG LIPING ; DUBOIS BYRON GABRIEL ; GUIADEEN DEODIALSINGH ; LIU PING ; SINZ CHRISTOPHER ; CAI JIAQIANG ; CRESPO ALEJANDRO ; KOTHANDARAMAN SHANKARAN ; DU XIAOXING ; QUAN WEIGUO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2017233412A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>LIU RONGQIANG</creatorcontrib><creatorcontrib>WANG LIPING</creatorcontrib><creatorcontrib>DUBOIS BYRON GABRIEL</creatorcontrib><creatorcontrib>GUIADEEN DEODIALSINGH</creatorcontrib><creatorcontrib>LIU PING</creatorcontrib><creatorcontrib>SINZ CHRISTOPHER</creatorcontrib><creatorcontrib>CAI JIAQIANG</creatorcontrib><creatorcontrib>CRESPO ALEJANDRO</creatorcontrib><creatorcontrib>KOTHANDARAMAN SHANKARAN</creatorcontrib><creatorcontrib>DU XIAOXING</creatorcontrib><creatorcontrib>QUAN WEIGUO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LIU RONGQIANG</au><au>WANG LIPING</au><au>DUBOIS BYRON GABRIEL</au><au>GUIADEEN DEODIALSINGH</au><au>LIU PING</au><au>SINZ CHRISTOPHER</au><au>CAI JIAQIANG</au><au>CRESPO ALEJANDRO</au><au>KOTHANDARAMAN SHANKARAN</au><au>DU XIAOXING</au><au>QUAN WEIGUO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INHIBITORS OF HIF PROLYL HYDROXYLASE</title><date>2017-08-17</date><risdate>2017</risdate><abstract>The present invention concerns compounds of formula I or pharmaceutically acceptable salts thereof, which inhibit HIF prolyl hydroxylase, their use for enhancing endogenous production of erythropoietin, and for treating conditions associated with reduced endogenous production of erythropoietin such as anemia and like conditions, as well as pharmaceutical compositions comprising such a compound and a pharmaceutical carrier.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2017233412A1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
title | INHIBITORS OF HIF PROLYL HYDROXYLASE |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T16%3A15%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LIU%20RONGQIANG&rft.date=2017-08-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2017233412A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |